Vancomycin Monitoring for Treatment of Acute Pulmonary Exacerbations of Adult Cystic Fibrosis Patients
Conclusion: In adult pwCF, the incidence of AKI was similar between AUC and trough monitoring cohorts; however, AUC monitoring achieved therapeutic targets sooner with fewer regimen modifications without significantly increasing the number of concentrations compared to trough monitoring.
Saved in:
| Main Authors: | Darrell Smith, James Sanders, Marguerite Monogue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Pulmonary Medicine |
| Online Access: | http://dx.doi.org/10.1155/pm/5683225 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
by: I. Wojsyk-Banaszak, et al.
Published: (2019-01-01) -
Species turnover within cystic fibrosis lung microbiota is indicative of acute pulmonary exacerbation onset
by: Leah Cuthbertson, et al.
Published: (2025-06-01) -
Variation in treatment preferences of pulmonary exacerbations among Australian and New Zealand cystic fibrosis physicians
by: Andre Schultz, et al.
Published: (2021-01-01) -
Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
by: Ashutosh Sharma, et al.
Published: (2017-01-01) -
Influence of Fungal Colonization on Exacerbations in Patients with Cystic Fibrosis
by: Claudia Janeth Madrid-Carbajal, et al.
Published: (2024-12-01)